Apyx Medical's Participation in Annual Growth Conference Revealed

Apyx Medical Corporation's Upcoming Conference Participation
Clearwater, Fla. — Apyx Medical Corporation (NASDAQ:APYX), known for its groundbreaking helium plasma and radiofrequency technologies, has made significant strides in its innovative healthcare solutions. The company is set to engage in the Canaccord Genuity 45th Annual Growth Conference happening soon.
Leadership Presence at the Conference
Representing Apyx Medical will be Charlie Goodwin, the President and CEO, alongside Matt Hill, the CFO. Their participation is not just about attending but also includes an engaging fireside chat that promises insights into the company's vision and strategies. This chat will take place in the afternoon and will feature discussions that are essential for potential investors and stakeholders alike.
Innovative Technology at the Forefront
Apyx Medical has gained recognition for its proprietary products, which include Renuvion and the AYON Body Contouring System. These advanced technologies target cosmetic surgery applications and offer significant benefits to both physicians and patients. Renuvion, in particular, has been highlighted for its ability to deliver controlled thermal energy to tissue, enhancing surgical outcomes while ensuring patient safety. This innovative approach sets Apyx apart from its competitors.
Clinical Backing and Efficacy
The technology behind Apyx Medical's products is backed by over 90 clinical publications, underscoring their commitment to efficacy and safety. This extensive research provides surgeons with the confidence to utilize Renuvion and J-Plasma in various surgical procedures, thereby improving patient care and reinforcing the company's reputation within the medical community.
Strategic One-on-One Investor Meetings
In addition to the fireside chat, Goodwin and Hill will host one-on-one meetings with potential investors. These meetings are an opportunity for stakeholders to discuss Apyx Medical's strategic direction, financial health, and growth potential. The management team is keen to share insights about their recent advancements and future projects, emphasizing transparency and fostering strong investor relationships.
Company Background and Vision
Apyx Medical Corporation is established within the medical device industry, focusing on advanced energy technologies. The company’s dedication to enhancing lives through innovative healthcare solutions is evident in its product lines. The AYON Body Contouring System and other medical products reflect its commitment to excellence and continual improvement in surgical practices. Apyx Medical also collaborates with other manufacturers through unique partnerships, which further enhances its technological capabilities.
Contact Information for Investors
For any inquiries or additional information about Apyx Medical Corporation's products and efforts, interested parties can reach out to Jeremy Feffer, Managing Director at LifeSci Advisors. His office can assist in addressing any investor queries, ensuring a consistent flow of communication. The contact number is 212-915-2568, and he is reachable at jfeffer@lifesciadvisors.com.
Frequently Asked Questions
What is Apyx Medical Corporation known for?
Apyx Medical Corporation is recognized for its innovative helium plasma and radiofrequency technologies, particularly Renuvion and AYON Body Contouring System.
When is the Canaccord Genuity Conference?
The Canaccord Genuity 45th Annual Growth Conference is scheduled for the near future, with specific dates being communicated during the management's presentations.
Who from Apyx Medical will be presenting?
Charlie Goodwin, the President and CEO, and Matt Hill, the Chief Financial Officer, will represent Apyx Medical at the conference.
What are the benefits of Renuvion technology?
Renuvion offers surgeons the ability to apply controlled thermal energy to tissues, improving patient outcomes and enhancing the efficacy of surgical procedures.
How can investors contact Apyx Medical?
Investors can contact Jeremy Feffer, Managing Director at LifeSci Advisors, at the phone number 212-915-2568 or via email at jfeffer@lifesciadvisors.com.
About The Author
Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.